(Q44198853)

30 November 2017

title

Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway (English)

1 reference

30 November 2017

1 reference

1 reference

Neumann E

1

1 reference

30 November 2017

Judex M

2

1 reference

30 November 2017

Kullmann F

3

1 reference

30 November 2017

Grifka J

4

1 reference

30 November 2017

Robbins PD

5

1 reference

30 November 2017

Pap T

6

1 reference

30 November 2017

Gay RE

7

1 reference

30 November 2017

Evans CH

8

1 reference

30 November 2017

Gay S

9

1 reference

30 November 2017

Schölmerich J

10

1 reference

30 November 2017

Müller-Ladner U

11

1 reference

30 November 2017

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

9

1 reference

30 November 2017

issue

22

1 reference

30 November 2017

page(s)

1508-1519

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301811

30 November 2017

exact match

0 references

cites work

Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Follistatins and alpha 2-macroglobulin are soluble binding proteins for inhibin and activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Activin A and follistatin: their role in the acute phase reaction and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Activin is a nerve cell survival molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Activin/EDF as an inhibitor of neural differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Activin receptors are expressed on human lung fibroblast and activin A facilitates fibroblast-mediated collagen gel contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Divergence and convergence of TGF-beta/BMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Expression of activin A in inflammatory arthropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21(Cip1) gene into the joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Adenoviral transfer of cyclin-dependent kinase inhibitor genes suppresses collagen-induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Involvement of p21(WAF1/Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Tumorigenic potential of extracellular matrix metalloproteinase inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Gene therapy in rheumatoid arthritis: how to target joint destruction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

"Inverse wrap": an improved implantation technique for virus-transduced synovial fibroblasts in the SCID mouse model for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

Molecular biology of cartilage and bone destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Comparative analysis of cathepsin l, cathepsin d, and collagenase messenger rna expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Measurement of transcription factor c-fos and EGR-1 mRNA transcription levels in synovial tissue by quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Treatment of rheumatoid arthritis patients with interleukin-1 receptor antagonist: radiologic assessment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Transfer and intra-articular expression of the IL-1Ra cDNA in human rheumatoid joints.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Follistatin and activin in bone: expression and localization during endochondral bone development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Expression of activin A is increased in cirrhotic and fibrotic rat livers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Activation of the IL-4 STAT pathway in rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301811

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301811

1 reference

30 November 2017

1 reference